Ichor’s next-generation TriGrid® Delivery System is an investigational device designed to enhance the intracellular delivery of nucleic acid constructs in muscle tissue with device refinements to support commercial deployment.
Like the early phase version, the next-gen device consists of a Pulse Stimulator, an Integrated Applicator and a single use Application Cartridge.
Device refinements include:
- Compatible with pre-filled syringe format
- Improved interface / usability / ergonomics
- On-board training / help / facilities installation modes
- Cart mounted or table top configuration with battery operation
- Full compliance with applicable international standards